智通财经APP讯，瑞丽医美(02135)发布公告，本集团预期截至2026年6月30日止六个月将录得收益约为人民币1.15亿元，而截至2025年6月30日止六个月则约为人民币8500万元;及本集团预期截至2026年6月30日止六个月将录得归属于母公司股东的盈利约为人民币400万元，而截至2025年6月30日止六个月则录得归属于母公司股东的亏损约为人民币800万元。
董事会认为，预期截至2026年6月30日止六个月业绩转亏为盈乃主要由于本集团期内收益增长使得毛利增加约人民币1500万元，该增长主要由(i)医疗美容服务收入增长;及(ii)医疗美容器械产品销售额增加所驱动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.